In short
Fibroid treatment follows symptoms and future plans, not size alone. Medicines control bleeding without shrinking much, myomectomy keeps the uterus but new fibroids can appear, and only hysterectomy rules out a return.
Emergency if: Go to an emergency department for bleeding that soaks a pad or tampon every hour for two hours or more, for fainting, for sudden severe abdominal pain, or for chest pain or sudden breathlessness after any fibroid procedure.
On your report
Hemoglobin, Ferritin, Serum Iron
On this page
01
Is Doing Nothing a Real Option?
It is, and for many people it is the right one. The NICHD guidance is that if you have fibroids but no symptoms or problems, you may not need treatment at all, and you can ask your provider to keep checking them at routine gynecological visits to see whether they have grown. Review articles agree that fibroids without symptoms do not require treatment regardless of their size.
Watchful waiting is not the same as ignoring the problem. It means tracking the things that would change the decision: how heavy and how long your periods are, whether pressure symptoms are worsening, and what your hemoglobin, ferritin and serum iron are doing over time. A blood count drifting downward is a concrete reason to move, in a way that a fibroid gaining a centimeter often is not.
It also buys time. Fibroid treatment is very rarely urgent, so trying the least invasive approach first and reassessing after a few months usually costs nothing but the months themselves. That is particularly true if you are within a few years of menopause, since falling hormone levels tend to shrink fibroids and end the bleeding that drives most treatment decisions. Waiting is a legitimate plan, provided somebody is actually watching the things that would change it.
02
Which Medicines Help, and What Can They Not Do?
For bleeding, NICE suggests considering a levonorgestrel intrauterine system as the first treatment when fibroids are under three centimeters and not distorting the cavity. If that is declined or unsuitable, the alternatives are tranexamic acid, non-steroidal anti-inflammatory drugs, combined hormonal contraception and cyclical oral progestogens, with the practical advice to keep using the non-hormonal options for as long as they are helping. Reviews describe tranexamic acid as effective for fibroid-related heavy bleeding, taken only on the heaviest days.
The limit is worth stating plainly, because it disappoints people who expected more. These treatments manage bleeding rather than the fibroids. The hormonal intrauterine system reduces heavy and painful bleeding but, as the NICHD puts it, does not treat the fibroids themselves; reviews advise against it when fibroids are submucosal, and expulsion is far more likely in a fibroid uterus, reported in up to one in five users. NICE adds that drug treatment may be less effective once fibroids are substantially greater than three centimeters, and the NICHD notes that when medical treatment stops, fibroids can grow back and symptoms return.
One group of medicines does shrink fibroids. GnRH agonists switch off the hormones that drive periods, reducing fibroid size, but they bring hot flashes, night sweats, vaginal dryness and bone loss, so they are not intended for long-term use. In practice they are given for a short period to shrink fibroids before surgery or to correct anemia first, and NICE supports considering this pretreatment before hysterectomy or myomectomy when fibroids have enlarged or distorted the uterus. Newer oral GnRH antagonists act on the same axis.
03
What Happened to Ulipristal?
Ulipristal acetate, sold as Esmya, is a hormone modulator that could slow or stop fibroid growth, reduce bleeding and improve symptoms, and it appears in guidance published while it was widely available, including NICE's list of options for fibroids of three centimeters or more. For a period it was one of the few drug treatments that shrank fibroids rather than only managing the bleeding.
Its situation changed. European regulators restricted its use after reports of rare but serious liver injury, requiring liver function testing before and during treatment and confining it to women whose surgery and embolization options had failed, were unsuitable or were declined. The European marketing authorization was then withdrawn on 18 July 2024, at the manufacturer's request and for commercial reasons rather than as a fresh safety ruling. Availability now differs sharply between countries, and in some it is no longer an option at all.
The general lesson matters more than this one drug. Guidance and articles about fibroids stay online long after the medicines they mention change status, and a drug can be restricted in one region while remaining available in another. So it is worth asking your clinician what is actually licensed and stocked where you are, what monitoring any drug treatment requires, and how long you would be expected to stay on it, rather than arriving with a name you read somewhere.
04
Which Operation Removes Fibroids but Keeps the Uterus?
Myomectomy removes only the fibroids and leaves the healthy uterus intact, which is why it is the operation offered when a future pregnancy matters. NICHD reports that studies show it relieves fibroid symptoms in 80 to 90 percent of women, which is a good result by the standards of this condition. The route into the uterus depends almost entirely on where the fibroids sit rather than on personal preference, so the scan report largely decides the operation.
Submucosal fibroids are removed hysteroscopically, through the vagina and cervix with no abdominal incision, and reviews note that fibroids under about four centimeters can be resected readily this way, with complication rates below one percent. Fibroids deeper in the wall are approached through the abdomen instead, either by keyhole surgery with a few small incisions or by open surgery. European good-practice recommendations put large FIGO type 2 to 3 fibroids and all type 4 to 7 fibroids in the abdominal group.
Between keyhole and open, the deciding factors are size, number, location, the surgical team's experience and your own preference. Well-selected patients can have keyhole myomectomy with complication rates under ten percent and a faster recovery, but large, multiple or cervical fibroids may not suit it. Open myomectomy gives excellent exposure for many or very large fibroids at the cost of more postoperative pain, more postoperative fever and a longer hospital stay. Robotic surgery behaves much like keyhole surgery, with higher charges.
05
What Are the Non-Surgical Procedures?
Uterine artery embolization is done through a small cut in the groin: a catheter is threaded into the vessels supplying the uterus and particles are injected to block blood flow to the fibroids, which then shrink. It works, but it is not permanent for everyone. The NICHD puts the proportion needing treatment again within five years at about one third, while a large claims analysis of reinterventions found closer to a quarter, so expect somewhere in that band rather than one figure. Its effect on pregnancy is unclear and an increased risk of miscarriage has been reported, so most providers do not recommend it for women who want children.
MRI-guided focused ultrasound uses an MRI scanner to locate fibroids and then directs focused sound waves through the skin to destroy them, with no incision at all. The NICHD says it is usually recommended for women who have only a few large fibroids, that symptoms improve for up to a year, and that within two years about one in three women need another surgery or procedure. Treatment reviews report broadly similar symptom relief with a lower repeat rate, and availability and insurance coverage remain patchy.
Radiofrequency ablation heats the fibroid through a fine needle placed under image guidance, and in practice is limited to fibroids of roughly five centimeters and under, around 110 cubic centimeters in volume, in FIGO types 0 to 4. Endometrial ablation is a different idea altogether: it destroys the lining of the uterus to control bleeding and is used for small fibroids inside the cavity, but pregnancy afterward is unlikely and carries a higher risk of miscarriage and other problems if it happens.
06
When Is Hysterectomy the Right Answer?
Removing the uterus ends fibroid symptoms permanently, because there is no longer anywhere for a fibroid to grow. It is the definitive option, and it is reserved for women who do not wish to preserve fertility or who have worked through less invasive treatments without adequate relief. It is a considered decision rather than a failure of the other options.
NICE asks for a full discussion before that decision is made, explicitly covering sexual feelings, the effect on fertility, bladder function, the possible need for further treatment, complications, your own expectations, alternative surgery and the psychological impact. It also asks that women be told about the increased risk of serious complications, such as bleeding during the operation or damage to other abdominal organs, when fibroids are present.
Surgery of any kind tends to be recommended in a recognizable set of situations: bleeding that has not responded to medicines, anemia caused by that bleeding, pressure or urinary symptoms from sheer bulk, a fertility indication such as a fibroid distorting the cavity, and, rarely, a rapidly enlarging pelvic mass where the diagnosis itself is in doubt and prompt specialist assessment is needed. If none of those describes you, it is fair to ask what the operation is expected to change.
07
Do Fibroids Grow Back After Treatment?
After a myomectomy the fibroids that were removed do not regrow, but new ones can develop, and that distinction explains most of the confusion around this question. In a large analysis of United States claims data, the proportion of women needing another intervention after myomectomy was 4.2 percent at one year and 19 percent by five years, broken down as 17 percent after abdominal, 20 percent after laparoscopic and 28 percent after hysteroscopic myomectomy.
For comparison, the same analysis found reintervention after uterine artery embolization at 7.0 percent at one year and 24 percent at five, and after endometrial ablation at 12.4 percent and 33 percent. So roughly one in five to one in four women need further treatment within five years, depending on the procedure. Fibroids seen again on a scan are considerably more common than fibroids that need treating again: reviews report around a 27 percent recurrence risk when a single fibroid was removed, and more than 50 percent when several were.
Age appeared in the claims analysis too, with women aged 30 to 44 showing a modestly higher hazard of reintervention than women aged 18 to 29, at hazard ratios of roughly 1.3 to 1.4. Read that cautiously, because the authors note the data lacked fibroid number, size and location, which are exactly the factors that drive recurrence. Hysterectomy is the one option after which fibroids cannot return.
08
What Should You Ask the Surgeon?
Start with the map and the plan. How many fibroids are there, what FIGO types are they, and which route is proposed and why. Ask what happens if the operation cannot be completed as planned, which usually means conversion from keyhole to open surgery, and under what circumstances a hysterectomy would be considered during the procedure. Ask what will be done to limit blood loss, since measures such as injected vasopressin, and vaginal misoprostol beforehand, have evidence behind them.
Then ask about recovery in your own terms. Registry data collected for European good-practice recommendations show a median return to usual activities of around 21 days after keyhole myomectomy and 28 days after open surgery, and return to work at about 21 days against 42 days, with substantial variation between populations. Those medians are a starting point for a conversation about your job, not a promise.
Finally, ask about what comes after. Will the uterine cavity be entered, and does that mean a planned cesarean in a future pregnancy. How long before it is reasonable to try to conceive. How likely is another procedure given the number of fibroids being removed, who will recheck your hemoglobin and iron stores afterward, and which symptoms should prompt a phone call once you are home.
When treatment needs revisiting, and when it is urgent
Routine — see a doctor
Go back for review if periods are still heavy after several months on medication, if you are tired and breathless on stairs, or if pressure and urinary symptoms are worsening, and ask for a repeat blood count with ferritin before deciding on a procedure.
Same-day — call promptly
Seek same-day assessment for fever, worsening pain, foul-smelling vaginal discharge, or a red, swollen or leaking wound in the weeks after fibroid surgery or embolization, and for new pain and swelling in one calf.
Emergency — act now
Go to an emergency department for bleeding that soaks a pad or tampon every hour for two hours or more, for fainting, for sudden severe abdominal pain, or for chest pain or sudden breathlessness after any fibroid procedure.
Values mentioned in this story
Each one opens a visual guide with its normal range and what moves it — upload a report and we place your own numbers on the same scale.
Sources
- Other treatments for fibroids — NICHDnichd.nih.gov
- Heavy menstrual bleeding: assessment and management (NICE NG88)ncbi.nlm.nih.gov
- Reintervention rates after myomectomy, endometrial ablation and uterine artery embolizationpmc.ncbi.nlm.nih.gov
- Esmya (ulipristal acetate) — European Medicines Agencyema.europa.eu
- Currently available treatment modalities for uterine fibroidspmc.ncbi.nlm.nih.gov
- ESGE good practice recommendations on surgical techniques for removal of fibroidspmc.ncbi.nlm.nih.gov
Share this story
Curious where your own values stand?
Two minutes from upload to a full visual picture. Free to analyze.